![Andreas Segerros](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andreas Segerros
Presidente presso
DEXTECH MEDICAL AB
Profilo
Andreas Rutger Segerros is currently Chief Executive Officer at Sylentis SAU since 2024.
Holds Chairman positions at Oncorena AB, Dextech Medical AB, and Oncorena Holding AB. Serves as Director at Prexton Therapeutics SA. Managing Partner at Eir Ventures Danmark ApS since 2020.
Formerly Chief Executive Officer at Nicox SA from 2022 to 2024.
Served as Chief Executive Officer at Clinitrac AB. Held Chairman role at CMC Contrast AB. Worked as Independent Director at Zyla Life Sciences LLC.
Director at Egalet Ltd. in 2011.
Director at RSPR Pharma AB. Head of Business Development & Operations Planning at Ferring Pharmaceuticals A. Principal at Pharmacia, Inc. Venture Partner at Sunstone Capital A from 2012 to 2019.
Education includes an MBA from the University of Uppsala and graduate studies at the Royal Institute of Technology.
Posizioni attive di Andreas Segerros
| Società | Posizione | Inizio |
|---|---|---|
| DEXTECH MEDICAL AB | Presidente | - |
Oncorena Holding AB
 Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Develops novel pharmacological treatment for metastasing clear cell renal cancer | Presidente | - |
Oncorena AB
 Oncorena AB Pharmaceuticals: MajorHealth Technology Develops a novel pharmacological treatment for metastasing clear cell renal cancer | Presidente | - |
Eir Ventures Danmark ApS
 Eir Ventures Danmark ApS Investment ManagersFinance Functions as an alternative investment manager | Investitore di Private Equity | 01/07/2020 |
Prexton Therapeutics SA
 Prexton Therapeutics SA Pharmaceuticals: MajorHealth Technology Provides novel therapeutic compounds for treatment of Parkinson disease and other brain disorders | Direttore/Membro del Consiglio | - |
Sylentis SA
 Sylentis SA BiotechnologyHealth Technology Operates as a biotechnology company that focuses on the development of new ophthalmic drugs and novel therapies based on RNAi technology | Amministratore Delegato | 29/05/2024 |
Precedenti posizioni note di Andreas Segerros
| Società | Posizione | Fine |
|---|---|---|
| NICOX SA | Amministratore Delegato | 28/02/2024 |
Sunstone Capital A/S
 Sunstone Capital A/S Investment ManagersFinance Sunstone is an active manager which provides equity funding for early-stage capital requirements, and provides management support. The firm targets companies operating in the technology and life sciences sector, and industries such as biotechnology, pharmaceuticals, and information technology services. Sunstone invests in companies located in Denmark and Northern Europe, and looks to take minority stake positions in its investments, as well as a seat on the board. | Investitore di Private Equity | 01/02/2019 |
Ferring Pharmaceuticals A/S
 Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Specializes in the development, production and marketing of pharmaceutical products | Corporate Officer/Principal | - |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░ ░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Formazione di Andreas Segerros
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
34
Relazioni di 1° grado
17
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 17 |
|---|---|
CMC Contrast AB
 CMC Contrast AB Pharmaceuticals: MajorHealth Technology develops magnetic resonance contrast agents for patients suffering with tumors | Health Technology |
Zyla Life Sciences LLC
 Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops medicines for patients with acute and chronic pain | Health Technology |
Nicox SA
 Nicox SA Pharmaceuticals: MajorHealth Technology Manufactures and sells ophthalmology biopharmaceuticals | Health Technology |
Ferring Pharmaceuticals A/S
Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Specializes in the development, production and marketing of pharmaceutical products | Health Technology |
Clinitrac AB
 Clinitrac AB Packaged SoftwareTechnology Services Develops wireless patient diaries | Technology Services |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Egalet Ltd.
 Egalet Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia, Inc. | |
Sunstone Capital A/S
Sunstone Capital A/S Investment ManagersFinance Sunstone is an active manager which provides equity funding for early-stage capital requirements, and provides management support. The firm targets companies operating in the technology and life sciences sector, and industries such as biotechnology, pharmaceuticals, and information technology services. Sunstone invests in companies located in Denmark and Northern Europe, and looks to take minority stake positions in its investments, as well as a seat on the board. | Finance |
RSPR Pharma AB
 RSPR Pharma AB Pharmaceuticals: MajorHealth Technology Develops therapeutics for inflammatory vascular diseases | Health Technology |
Sylentis SA
Sylentis SA BiotechnologyHealth Technology Operates as a biotechnology company that focuses on the development of new ophthalmic drugs and novel therapies based on RNAi technology | Health Technology |
Oncorena AB
Oncorena AB Pharmaceuticals: MajorHealth Technology Develops a novel pharmacological treatment for metastasing clear cell renal cancer | Health Technology |
Prexton Therapeutics SA
Prexton Therapeutics SA Pharmaceuticals: MajorHealth Technology Provides novel therapeutic compounds for treatment of Parkinson disease and other brain disorders | Health Technology |
Dextech Medical AB
 Dextech Medical AB Pharmaceuticals: MajorHealth Technology Engages in the research and development of drug candidates for urologic oncology | Health Technology |
Oncorena Holding AB
Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Develops novel pharmacological treatment for metastasing clear cell renal cancer | Health Technology |
Eir Ventures Danmark ApS
Eir Ventures Danmark ApS Investment ManagersFinance Functions as an alternative investment manager | Finance |
